{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-115360","form_type":"8-K","ticker":"GDRX","cik":"0001809519","company_name":"GoodRx Holdings, Inc.","filed_at":"2023-04-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.709940+00:00","generated_at":"2026-06-16T16:41:10.141105+00:00","sec_items":["2.02","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"medium","headline":"GoodRx appoints Scott Wagner as Interim CEO; co-founders transition to Chairman and Chief Mission Officer","bullets":["Scott Wagner, former CEO of GoDaddy, named Interim CEO effective April 25, 2023.","Co-founders Trevor Bezdek becomes Chairman, Doug Hirsch becomes Chief Mission Officer.","Wagner receives base salary, 100% target bonus, and option grant for 2.5M-3M shares vesting monthly.","Bezdek and Hirsch each retain $500K base salary and 100% target bonus under 18-month employment agreements.","Press release notes Q1 Monthly Active Consumers in range; full results on May 10 earnings call."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-115360","json":"https://secwatch.observer/filing/0001193125-23-115360.json","markdown":"https://secwatch.observer/filing/0001193125-23-115360.md","text":"https://secwatch.observer/filing/0001193125-23-115360.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1809519/000119312523115360/0001193125-23-115360-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1809519/000119312523115360/d436463d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T16:41:10.141105+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"84a8141836c57bfaa1e4b3ee1736d62a37450e7a","claim":"GoodRx Holdings, Inc. reported financial results for the first quarter ended March 31, 2023.","evidence_excerpt":"On April 25, 2023, GoodRx Holdings, Inc. (the “Company”) issued a press release in connection with the executive leadership transition described in Item 5.02 of this Current Report on Form 8-K which addresses the Company’s financial performance for the first quarter ended March 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1809519/000119312523115360/0001193125-23-115360-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"06bd9a2ade","claim":"Scott Wagner was appointed as Interim Chief Executive Officer at GoodRx Holdings, Inc..","evidence_excerpt":"the Company’s Board of Directors (the “Board”) appointed Scott Wagner as Interim Chief Executive Officer of the Company (principal executive officer), effective April 25, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1809519/000119312523115360/0001193125-23-115360-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"4f6f791be0","claim":"Douglas Hirsch changed role as Chief Mission Officer at GoodRx Holdings, Inc..","evidence_excerpt":"Messrs. Bezdek and Hirsch will each remain executive officers of the Company, serving as Chairman and Chief Mission Officer, respectively","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1809519/000119312523115360/0001193125-23-115360-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"transitioned"},{"label":"Role","value":"Chief Mission Officer"}],"fact_type":"executive_change"},{"claim_id":"d0e9f0942a","claim":"Trevor Bezdek changed role as Chairman at GoodRx Holdings, Inc..","evidence_excerpt":"Messrs. Bezdek and Hirsch will each remain executive officers of the Company, serving as Chairman and Chief Mission Officer, respectively","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1809519/000119312523115360/0001193125-23-115360-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"transitioned"},{"label":"Role","value":"Chairman"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}